[Federal Register Volume 85, Number 128 (Thursday, July 2, 2020)]
[Notices]
[Pages 39910-39911]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-14331]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-20-20PJ; Docket No. CDC-2020-0073]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``Formative Research on
Community-Level Factors that Promote the Primary Prevention of Adverse
Childhood Experiences (ACEs) and Opioid Misuse Among Children, Youth,
and Families in Tribal American Indian and Alaska Native (AI/AN)
Communities.'' The proposed collection is designed to conduct formative
qualitative studies to identify community-level protective factors and
primary prevention strategies across a range of Tribal communities to
prevent adverse childhood experiences (ACEs) and opioid misuse.
DATES: CDC must receive written comments on or before August 31, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0073 by any of the following methods:
Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to http://www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (http://www.regulations.gov) or by U.S. mail to the address
listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Formative Research on Community-Level Factors That Promote the Primary
Prevention of Adverse Childhood Experiences (ACEs) and Opioid Misuse
Among Children, Youth, and Families in Tribal American Indian and
Alaska Native (AI/AN) Communities--New--National Center for Injury
Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC)
Background and Brief Description
Adverse childhood experiences (ACEs) are preventable, potentially
traumatic events that occur in childhood (0-17 years) such as
experiencing violence, abuse, or neglect; witnessing violence in the
home; and having a family member attempt or die by suicide. There is a
robust evidence base linking ACEs to a variety of poor health outcomes
across the life span, including depression, alcohol and substance use
disorder, and violence perpetration and victimization. The ongoing
opioid epidemic is a complex and significant public health crisis that
exposes children to opioid misuse, violence, and other ACEs, and
challenges the ability of Health and Human Service (HHS) systems to
mitigate the effects of opioid misuse and ACEs on children and families
across the U.S. American Indian/Alaska Native (AI/AN) populations
experience a disproportionate burden of opioid misuse and ACEs, and
ACE-related
[[Page 39911]]
health outcomes, including opioid overdose, sexual assault, and suicide
attempts. The nature and consequences of ACEs in Tribal communities is
unique because of historical trauma and stark socioeconomic
disparities. In addition, there are gaps in the provision of adequate
healthcare.
This collection addresses critical research gaps and extends
efforts to prevent violence and other ACEs before they occur and to
build evidence of effectiveness of community-level strategies and
approaches at the outer levels of the social ecology to Tribal
communities. Results from this data collection will be communicated to
relevant public health officials and community stakeholders in the
study locations. These local public health officials and community
stakeholders will use the study results to guide strategies to further
strengthen their local prevention efforts within their regions.
Data collection methods used in this study include well-established
qualitative methods, including in-depth open-ended individual
interviews and focus groups. Quantitative methods include brief
structured surveys. There will be a total of six Tribal communities
(three urban and three rural) in regions identified with higher opioid
overdose mortality rates relatively to other areas in Indian Country.
Due to COVID-19, at the time of the focus groups/interviews, social
distancing and public health safety measures will be implemented,
including considerations for phone/virtual meetings instead of in-
person sessions.
The total estimated annualized burden hours are 918. There are no
costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Data collection respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Adults 18 years or older Information 336 1 5/60 28
affected by the opioid Letter. 336 1 20/60 112
epidemic living in Tribal Telephone 252 1 3/60 13
urban and rural communities. screening.
Confirmation
email/letter.
Reminder email.. 252 1 2/60 9
Informed Consent 252 1 15/60 63
Survey.......... 252 1 45/60 189
Focus group/ 252 1 2 504
interview.
---------------------------------------------------------------
Total................. ................ .............. .............. .............. 918
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-14331 Filed 7-1-20; 8:45 am]
BILLING CODE 4163-20-P